Recalls / Class II
Class IID-1172-2018
Product
Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
- Affected lot / code info
- Lot #: 0116158 Exp. 4/30/19; 0113903, 0113902, 0113901, Exp. 8/31/18
Why it was recalled
Supterpotent Drug
Recalling firm
- Firm
- Mckesson Corporation
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 4836 Southridge Blvd, N/A, Memphis, Tennessee 38141-8300
Distribution
- Quantity
- 1531 cartons
- Distribution pattern
- Nationwide within the United States
Timeline
- Recall initiated
- 2018-08-14
- FDA classified
- 2018-09-05
- Posted by FDA
- 2018-09-12
- Terminated
- 2020-11-25
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1172-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.